| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/07/1998 | EP0815864A1 Semi-solid composition containing an antiflatulent agent |
| 01/07/1998 | EP0815863A1 Combination of s-adenosylmethionine and azidothymidine for inhibiting HIV-replication |
| 01/07/1998 | EP0815862A1 Ophthalmological composition comprising activated vitamin d |
| 01/07/1998 | EP0815861A1 Sulphonamides and their use |
| 01/07/1998 | EP0815860A2 Terfenadine carboxylate and the treatment of allergic disorders |
| 01/07/1998 | EP0815859A1 Intimal thickening inhibitors |
| 01/07/1998 | EP0815858A1 Pharmaceutical composition for the treatment of leukemia containing 9-cis-retinoic acid-alpha-tocopherol ester |
| 01/07/1998 | EP0815857A1 Antiobestic agent containing procyanidin as the active ingredient |
| 01/07/1998 | EP0815856A2 Retroviral protease inhibitors |
| 01/07/1998 | EP0815855A1 Multiphase soft gelatin dosage form |
| 01/07/1998 | EP0815845A1 Cosmetic and/or dermatological acidic composition containing a crosslinked and at least 90% neutralized polymer of 2-acrylamide-2-methylpropane sulfonic acid |
| 01/07/1998 | EP0815840A2 Method for the treatment or prevention of intrinsically aged skin with retinoids |
| 01/07/1998 | EP0815446A1 Method of identifying molecules that regulate fgf activity |
| 01/07/1998 | EP0815240A1 Novel human cyclin-dependent kinase-like proteins and methods of using the same |
| 01/07/1998 | EP0815231A2 Use of neuronal apoptosis inhibitor protein (naip) |
| 01/07/1998 | EP0815218A2 Human vegf-specific antisense oligonucleotides |
| 01/07/1998 | EP0815216A2 Antisense transcript expressed in b lymphocytes and synthetic oligonucleotides useful to inhibit the activity thereof |
| 01/07/1998 | EP0815215A2 An antisense transcript associated to tumor cells having a t(14;18) translocation and oligodeoxynucleotides useful in the diagnosis and treatment of said tumor cells |
| 01/07/1998 | EP0815204A1 Method for treating tumors |
| 01/07/1998 | EP0815201A1 Methods for microbial regulation |
| 01/07/1998 | EP0815144A1 Process for glucan preparation and therapeutic uses of glucan |
| 01/07/1998 | EP0815134A1 Modulators of amyloid aggregation |
| 01/07/1998 | EP0815129A1 Ingap protein involved in pancreatic islet neogenesis |
| 01/07/1998 | EP0815127A1 Fucopeptides |
| 01/07/1998 | EP0815124A1 Heterocyclecarbonyl amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 01/07/1998 | EP0815123A1 $g(b)-SHEET MIMETICS AND USE THEREOF AS PROTEASE INHIBITORS |
| 01/07/1998 | EP0815120A1 17-difluoromethylene-oestratrienes |
| 01/07/1998 | EP0815116A1 Inhibition and modulation of gonadotropin-releasing hormone receptor activity |
| 01/07/1998 | EP0815113A1 Water-soluble esters of camptothecin compounds |
| 01/07/1998 | EP0815112A1 Process for isolating galanthamine |
| 01/07/1998 | EP0815111A1 Analogues of n-acetylardeemin, method of preparation and uses thereof |
| 01/07/1998 | EP0815107A1 Morpholine derivatives, compositions containing them and their use as therapeutic agents |
| 01/07/1998 | EP0815105A1 Heterocyclic substituted piperazinone derivatives as tachykinin receptor antagonists |
| 01/07/1998 | EP0815104A1 3-benzylamino-2-phenylpiperidines as neurokinin antagonists |
| 01/07/1998 | EP0815103A1 Trypsin and thrombin inhibitors |
| 01/07/1998 | EP0815100A1 Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
| 01/07/1998 | EP0815099A1 Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
| 01/07/1998 | EP0815096A1 Cephalomannine epoxide, its analogues and a method for preparing the same |
| 01/07/1998 | EP0815095A1 10-DEACETYLBACCATINE III AND 10-DEACETYL 14$g(b)-HYDROXYBACCATINE III DERIVATIVES, A PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
| 01/07/1998 | EP0815088A1 Aromatic compounds useful as tachykinin antagonists |
| 01/07/1998 | EP0815087A1 Trisubstituted phenyl derivatives |
| 01/07/1998 | EP0815084A1 Lactam-containing hydroxamic acid derivatives, their preparation and their use as inhibitors of matrix metalloprotease |
| 01/07/1998 | EP0815081A1 Piperidinyl-2-alkyl subst. linear polyamines for the reduction of intracellular, endogenic polyamine levels such as putrescine, spermidine and spermine, and their impact on cell proliferation |
| 01/07/1998 | EP0815080A1 Di-substituted 1,4-piperidine esters and amides having 5-ht 4? antagonistic activity |
| 01/07/1998 | EP0814847A1 Methods and compositions for in-vivo detection of oral cancers and precancerous conditions |
| 01/07/1998 | EP0814844A2 Thyroxine/cyclodextrin complexes and pharmaceutical compositions containing the same |
| 01/07/1998 | EP0814842A1 Method for treating amyloidosis |
| 01/07/1998 | EP0814840A1 Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a prokinetic agent |
| 01/07/1998 | EP0814839A1 Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a nsaid |
| 01/07/1998 | EP0814831A1 Method for treatment of autoimmune diseases using interferon-tau |
| 01/07/1998 | EP0814825A1 Method of treating or preventing non-viral microbial infection |
| 01/07/1998 | EP0814823A1 Polyphenol fractions of tea, the use thereof and formulations containing them |
| 01/07/1998 | EP0814815A1 Poly(hydroxy acid)/polymer conjugates for skin applications |
| 01/07/1998 | EP0814814A1 Methods for the treatment of thrombosis |
| 01/07/1998 | EP0814813A2 Use of penciclovir for the treatment of human herpes-virus-8 |
| 01/07/1998 | EP0814812A1 Compositions comprising nicotynylalanine and an inhibitor of glycine conjugation or vitamin b6 |
| 01/07/1998 | EP0814811A1 Once-a-month-injectable useful as depot contraceptive and in hormone replacement therapy for perimenopausal and premenopausal women |
| 01/07/1998 | EP0814810A1 Adenosine as a positive inotrop in the compromised heart |
| 01/07/1998 | EP0814809A1 Aryl thioxanthines |
| 01/07/1998 | EP0814808A1 Pharmaceutical, cosmetic and/or food composition having anti-oxidant properties |
| 01/07/1998 | EP0814807A1 Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
| 01/07/1998 | EP0814806A1 Use of fused benzothiazoles as neuroprotectants |
| 01/07/1998 | EP0814805A1 Process and products for reducing biological fluid levels of a lipid soluble waste |
| 01/07/1998 | EP0814804A1 Substituted benzopyrans |
| 01/07/1998 | EP0814803A2 Use of anti-oestrogens as male contraceptives |
| 01/07/1998 | EP0814802A2 Method of reducing prolonged coagulation time |
| 01/07/1998 | EP0814801A2 Use of a pyruvate dehydrogenase activator for the treatment of ischaemia in limbs |
| 01/07/1998 | EP0814800A1 Water-based topical cream containing nitroglycerin; method of preparation and use thereof |
| 01/07/1998 | EP0814799A1 Use of retinoids for the manufacture of a medicament for the treatment of restenosis |
| 01/07/1998 | EP0814798A1 The pharmacological use of certain cystine derivatives |
| 01/07/1998 | EP0814797A1 Parenteral pharmaceutical compositions containing ammoniumalkyl salts of 2-arylpropionic acids |
| 01/07/1998 | EP0814796A2 Use of a r-nsaid in a protective composition for the treatment of colorectal cancer |
| 01/07/1998 | EP0814795A2 Use of betulinic acid and its derivatives for inhibiting malignant melanoma growth and a method of monitoring this |
| 01/07/1998 | EP0814794A1 Lidocaine-vasoconstrictor aerosol preparation |
| 01/07/1998 | EP0814793A1 Prilocaine and hydrofluorocarbon aerosol preparations |
| 01/07/1998 | EP0814792A1 Mercapto and seleno derivatives as inhibitors of nitric oxide synthase |
| 01/07/1998 | EP0814791A1 Aminotetralin derivative for the therapy of cardiovascular diseases |
| 01/07/1998 | EP0814790A1 Nasal and ocular administration of ketamine to manage pain and for detoxification |
| 01/07/1998 | EP0814789A1 Pharmaceutical compositions comprising monoamine oxidase b inhibitors |
| 01/07/1998 | EP0814788A1 Improving glucose tolerance |
| 01/07/1998 | EP0814787A1 Oil in water emulsions containing propofol and edetate |
| 01/07/1998 | EP0814786A2 Pinitol and derivatives thereof for the treatment of metabolic disorders |
| 01/07/1998 | EP0814785A1 Use of nitric oxide donors or nitric oxide inhibitors for regulating cervical dilatation and extensibility |
| 01/07/1998 | EP0814784A1 Use of ketorolac for treatment of squamous cell carcinomas of the oral cavity or oropharynx |
| 01/07/1998 | EP0814783A1 Multiple unit effervescent dosage forms comprising protonpump inhibitor |
| 01/07/1998 | EP0814782A1 Pharmaceutical composition stabilized with a basic agent |
| 01/07/1998 | EP0814780A1 Diltiazem controlled release formulation |
| 01/07/1998 | EP0814776A1 Topically applied pharmaceutical composition, method of preparing it and its use |
| 01/07/1998 | EP0814775A1 Method and kit for preventing erectile dysfunction |
| 01/07/1998 | EP0814771A1 Improvements in or relating to organic compositions |
| 01/07/1998 | EP0814770A1 Process for the preparation of a solid pharmaceutical dosage form |
| 01/07/1998 | EP0814769A1 Aerosolized general anesthetic agents |
| 01/07/1998 | EP0814763A1 Depigmenting dermatological and/or cosmetic composition |
| 01/07/1998 | EP0814759A1 Sunscreen compositions comprising a mixture of titanium and/or zinc oxide particles, method for preparing the same and use thereof |
| 01/07/1998 | EP0814660A1 Topical antimicrobial agents |
| 01/07/1998 | EP0713527A4 Fungicidal methods and compositions for killing yeast and sporular microorganisms |
| 01/07/1998 | EP0703910B1 Benzoylbenzofurane derivatives for treatment of cardiac arrhythmia |
| 01/07/1998 | EP0673370B1 Tropone-substituted phenyloxazolidinone antibacterial agents |
| 01/07/1998 | EP0672032B1 Novel phenylethyl and phenylpropylamines |
| 01/07/1998 | EP0669909B1 Substituted amidino compounds, their manufacture and methods of treatment |